tiprankstipranks
Trending News
More News >
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI

Compare Bioxcel Therapeutics (BTAI) vs. Competitors

Compare
1,912 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Bioxcel Therapeutics
$2.02
$43.96M
-0.21
-66.53%
1 Buy
0 Hold
1 Sell
Hold
Actinium Pharmaceuticals
$1.30
$43.36M
-1.17
11.72%
3 Buy
0 Hold
0 Sell
Strong Buy
Kezar Life Sciences
$6.14
$45.40M
-0.73
-5.68%
0 Buy
3 Hold
0 Sell
Hold
Annovis Bio
$3.45
$97.27M
-2.33
-19.84%
2 Buy
0 Hold
0 Sell
Moderate Buy
BioAtla
$0.40
$21.26M
-0.27
-24.67%
1 Buy
0 Hold
0 Sell
Moderate Buy
Century Therapeutics
$1.77
$169.57M
-6.56
78.79%
1 Buy
1 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BTAI
Bioxcel Therapeutics
2.02
-3.69
-64.62%
ATNM
Actinium Pharmaceuticals
1.30
0.08
6.56%
KZR
Kezar Life Sciences
6.14
-0.07
-1.13%
ANVS
Annovis Bio
3.45
-1.22
-26.12%
BCAB
BioAtla
0.31
-0.19
-37.20%
IPSC
Century Therapeutics
2.04
1.11
118.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts